Applied Therapeutics Inc [APLT] stock is trading at $0.13, up 0.16%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The APLT shares have gain 7.01% over the last week, with a monthly amount drifted -55.40%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Applied Therapeutics Inc [NASDAQ: APLT] stock has seen the most recent analyst activity on December 12, 2025, when Robert W. Baird downgraded its rating to a Neutral. Previously, Leerink Partners downgraded its rating to Market Perform on December 03, 2025, and kept the price target unchanged to $1. On December 23, 2024, downgrade downgraded it’s rating to Mkt Perform. UBS downgraded its rating to a Neutral and decreased its price target to $2 on December 02, 2024. RBC Capital Mkts downgraded its rating to a Sector Perform and reduced its price target to $4 on November 29, 2024. In a note dated March 26, 2024, RBC Capital Mkts initiated an Outperform rating and provided a target price of $12 on this stock.
Applied Therapeutics Inc [APLT] stock has fluctuated between $0.10 and $1.50 over the past year. Currently, Wall Street analysts expect the stock to reach $0.25 within the next 12 months. Applied Therapeutics Inc [NASDAQ: APLT] shares were valued at $0.13 at the most recent close of the market. An investor can expect a potential return of 92.31% based on the average APLT price forecast.
Analyzing the APLT fundamentals
Applied Therapeutics Inc [NASDAQ:APLT] reported sales of 1.00M for the trailing twelve months, which represents a growth of 719.67%. Gross Profit Margin for this corporation currently stands at -0.29% with Operating Profit Margin at -98.4%, Pretax Profit Margin comes in at -18.14%, and Net Profit Margin reading is -18.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.53, Equity is -0.66 and Total Capital is -66.85. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-4.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1204 points at the first support level, and at 0.1156 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1310, and for the 2nd resistance point, it is at 0.1368.
Ratios To Look Out For
For context, Applied Therapeutics Inc’s Current Ratio is 0.96. In addition, the Quick Ratio stands at 0.96 and the Cash Ratio stands at 0.36. Considering the valuation of this stock, the price to sales ratio is 18.07.
Transactions by insiders
Recent insider trading involved Kanter Stacy J., Director, that happened on Dec 16 ’25 when 43000.0 shares were sold. Director, Stacy J. Kanter completed a deal on Dec 16 ’25 to buy 43000.0 shares. Meanwhile, Chief Medical Officer Perfetti Riccardo sold 10366.0 shares on Mar 04 ’25.
